QQQ $ 628.80 $ 0.00 (0 %)
DIA $ 476.48 $ 0.00 (0 %)
SPY $ 685.38 $ 0.00 (0 %)
TLT $ 91.96 $ 0.00 (0 %)
GLD $ 360.17 $ 0.00 (0 %)
$ 49.88
$ 49.96
$ 50.22 x 200
$ 50.46 x 725
-- - --
$ 44.12 - $ 56.29
3,157,045
na
27.59B
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

UBS analyst Marcus Cole maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $49 to $52.

Core News & Articles

Wells Fargo analyst Timna Tanners initiates coverage on Amrize (NYSE:AMRZ) with a Overweight rating and announces Price Targ...

 darden-humana-and-rocket-lab-are-among-top-10-large-cap-losers-last-week-sep-15--sep-19-are-the-others-in-your-portfolio

Darden, Humana, Rocket Lab, and FactSet led last week's large-cap losers, with declines driven by weak earnings, guidance, ...

Core News & Articles

Oppenheimer analyst Bryan Blair initiates coverage on Amrize (NYSE:AMRZ) with a Outperform rating and announces Price Target...

Core News & Articles

JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $52 to $60.

Core News & Articles

RBC Capital analyst Anthony Codling maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $61 to $54.

Core News & Articles

Amrize, Meta and the University of Illinois partnership accelerates innovation and adoption of AI-optimized concrete mixesAdvan...

Core News & Articles

JP Morgan analyst Adrian Huerta initiates coverage on Amrize (NYSE:AMRZ) with a Overweight rating and announces Price Target...

Core News & Articles

Bernstein analyst Pujarini Ghosh initiates coverage on Amrize (NYSE:AMRZ) with a Outperform rating and announces Price Targe...

Core News & Articles

Goldman Sachs analyst Jerry Revich initiates coverage on Amrize (NYSE:AMRZ) with a Neutral rating and announces Price Target...

Core News & Articles

B of A Securities analyst Arnaud Lehmann initiates coverage on Amrize (NYSE:AMRZ) with a Neutral rating and announces Price ...

Core News & Articles

Truist Securities analyst Keith Hughes initiates coverage on Amrize (NYSE:AMRZ) with a Buy rating and announces Price Target...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION